Company Information

  

Address: SOVEREIGN HOUSE
VISION PARK 
City: HISTON, CAMBRIDGE CB24 9BZ 
State:  
Zip Code: 00000 
Telephone: 44 1223 266800 

Description of Business

Primary SIC Code: 2834
(As filed with the SEC)  

GW Pharmaceuticals plc was founded in 1998 and is a public limited company incorporated under the laws of England and Wales. Our ordinary shares were admitted to trading on the Alternative Investment Market, or AIM, a market operated by London Stock Exchange plc, under the symbol GWP on June 28, 2001. The admission of our ordinary shares to trading on AIM was cancelled with effect from 7.00am on December 5, 2016. On May 1, 2013, we completed our initial public offering of American Depositary Shares, or ADSs, on the NASDAQ Global Market. Our ADSs are traded under the symbol GWPH. Our registered and principal executive offices are located at Sovereign House, Vision Park, Chivers Way, Histon, Cambridge, CB24 9BZ, United Kingdom, our general telephone number is (44) 1223 266-800 and our internet address is http://www.gwpharm.com. Our website and the information contained on or accessible through our website are not part of this document.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
09/2016-0.30NAN/E
09/2015-0.27NAN/E
09/2013-0.60NAN/E

Key Financial Ratios and Statistics

FYE: 09/30

Profitability 2016 Leverage 2016
Net Inc/Comm Equity-0.11Total Liab/Total Assets0.12
Net Inc/Total Assets-0.14Total Liab/Inv Cap0.13
Net Inc/Inv Cap-0.15Total Liab/Comm Equity0.10
Pretax Inc/Net Sales-8.35Interest Coverage Ratio-496.50
Net Inc/Net Sales-6.17Curr Debt/Equity0.00
Cash Flow/Net Sales-8.20LTD/Equity0.04
SG&A/NetSales1.93Total Debt/Equity0.04
Asset Utilization   Liquidity  
Net Receivables Turnover0.47Quick Ratio11.45
Inventory Turnover0.56Current Ratio11.57
Inventory Day Sales0.00Net Rec/Curr Assets0.06
Net Sales/Work Cap0.03Inv/Curr Assets0.01
Net Sales/PP&E0.26  

Income Statement (Millions)

  9/30/2016 9/30/2015 9/30/2014 9/30/2013
Total Revenues(Net Sales) 13.40 43.23 48.71 44.20
Cost of Goods Sold 3.53 3.97 3.34 2.07
Selling & Admin Exps 25.90 19.04 11.89 5.76
Operating Income -112.50 -86.69 -31.84 -16.96
Interest Exp 0.23 0.11 0.10 0.10
Pretax Income -111.94 -86.43 -31.73 -16.77
Other Income 33.98 9.77 5.38 -0.10
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -82.69 -67.50 -23.77 -7.37

Balance Sheet (Millions)

Assets 9/30/2016 9/30/2015 9/30/2014 9/30/2013
Cash & Short Term Investments 486.34 355.78 266.67 61.65
Receivables - Total 33.62 23.50 11.52 7.50
Inventories - Total 5.52 7.20 7.74 7.55
Total Current Assets 525.47 386.48 285.94 76.70
Net Property, Plant & Equipment 50.59 43.52 18.87 8.87
Total Assets 588.68 438.90 313.70 95.45
Liabilities        
Accounts Payable 41.64 36.94 20.06 15.29
Debt in Current Liabilities 0.27 0.17 0.20 0.16
Total Current Liabilities 45.40 42.06 28.09 20.60
Long-Term Debt 18.68 15.13 15.74 3.09
Total Liabilities 71.04 67.37 56.61 38.12
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock NA NA NA NA
Common Stock 0.39 0.40 0.38 0.29
Retained Earnings -231.00 -187.01 -132.07 -111.68
Treasury Stock NA NA NA NA
Total Stockholders' Equity 517.64 371.53 257.09 57.33
Total Liabilities and Stockholders' Equity 588.68 438.90 313.70 95.45

Cash Flow Summary (Millions)

Categories 9/30/2016 9/30/2015 9/30/2014 9/30/2013
Net Cash Provided by Operating Activities -109.89 -70.39 -20.47 -12.09
Net Cash Provided by Investing Activities -11.37 -26.95 -11.50 -3.36
Net Cash Provided by Financing Activities 268.64 194.52 233.88 29.56

Annual Summary Data (Millions)

Year Sales Net Income EPS
09/201253.484.02--
09/201344.20-7.37-0.60
09/201448.71-23.76--
09/201543.23-67.50-0.27
09/201613.40-82.69-0.30
Growth Rates-29.25----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional09/30/1719719,63377.90




Report Date : 10/16/2017

Powered By Edgar Online © 2017EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.